NCT01639729View on ClinicalTrials.gov

Effect of Delivery Route on PK of Sufentanil NanoTab

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Pharmacokinetics
Interventions
DRUG

Treatment A: Sufentanil IV

Sufenta IV (50 mcg/mL) 15 mcg push over 1 minute (IV)

DRUG

Treatment B: Sufentanil NanoTab Sublingual

Single Sufentanil NanoTab 15 mcg given sublingually (SL)

DRUG

Treatment C: Sufentanil NanoTab Buccal

Treatment C: Single Sufentanil NanoTab 15 mcg given buccally (BU)

DRUG

Treatment D: Sufentanil NanoTab Oral

Single Sufentanil NanoTab 15 mcg swallowed (PO)

Trial Locations (1)

66219

PRA, Lenexa

All Listed Sponsors
lead

Talphera, Inc

INDUSTRY

NCT01639729 - Effect of Delivery Route on PK of Sufentanil NanoTab | Biotech Hunter | Biotech Hunter